For citations:
Zyryanov S.K., Orlova K.V. Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(4):550-569. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.221
Views PDF (Rus): 209
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 